| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |